Broken out by business line, first quarter net sales from Biomet’s joint constructive products totaled $393 million. Sports, extremities and trauma units reaped $127.3 million, while spine and bone healing units totaled $77.9 million. Quarterly outcomes included Biomet’s acquisition of DePuy’s trauma operations.
More Articles on Orthopedic Devices:
Smith & Nephew Launches TRIGEN Low-Profile Screw
